About: Targeting apoptosis pathways by Celecoxib in cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Targeting apoptosis pathways by Celecoxib in cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 22 February 2011

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2011 (ast) наукова стаття, опублікована в лютому 2011 (uk) مقالة علمية نشرت في 22 فبراير 2011 (ar) scientific article published on 22 February 2011 (en)
publication date	wds:Q37846306-1803BC6D-D83B-4937-9BED-665C52278F87
publication date	2011-02-22 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37846306-F70AC22B-C9A9-4446-9139-33C8EFC2AC39
language of work or name	English
cites work	wds:Q37846306-4D462312-6DA8-4113-9FDC-9B012B897668
cites work	BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.
author name string	wds:Q37846306-45507B41-854A-4201-8689-4FC9BD3DA462
author name string	Verena Jendrossek
rdfs:label	Targeting apoptosis pathways by Celecoxib in cancer (en) Targeting apoptosis pathways by Celecoxib in cancer (nl) Targeting apoptosis pathways by Celecoxib in cancer (ast)
skos:prefLabel	Targeting apoptosis pathways by Celecoxib in cancer (en) Targeting apoptosis pathways by Celecoxib in cancer (nl) Targeting apoptosis pathways by Celecoxib in cancer (ast)
name	Targeting apoptosis pathways by Celecoxib in cancer (en) Targeting apoptosis pathways by Celecoxib in cancer (nl) Targeting apoptosis pathways by Celecoxib in cancer (ast)
title	wds:Q37846306-667284A1-B6E4-466E-8E3D-F743E54177BF
title	Targeting apoptosis pathways by Celecoxib in cancer (en)
page(s)	wds:Q37846306-D3D56E3B-A95E-4964-8400-EDB4B518F4B3
page(s)	313-324
instance of	wds:Q37846306-2BFE786B-1F26-4AA1-B17F-276304D7C84F wds:Q37846306-f9b70bda-60e7-4266-8a62-5aa1c892c630
instance of	review article scholarly article
main subject	wds:Q37846306-D15272B4-E4C6-4BB7-AF33-825EF976F1CB
main subject	apoptotic process
PubMed ID	wds:Q37846306-90EDAA04-FCF6-4730-A624-A90B6DABE469
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21345578
PubMed ID	21345578
published in	wds:Q37846306-0C29BAF7-98B9-4B20-82AE-B8E335028999
published in	Cancer Letters
issue	wds:Q37846306-209B2D86-D589-4006-9342-B14E27959AFA
volume	wds:Q37846306-1C078F47-115F-46C6-B465-61176E166FA6
issue	2
volume	332
DOI	wds:Q37846306-0F9243A5-0E70-4FB6-A198-B594320A5DAA
DOI	http://dx.doi.org/10.1016/J.CANLET.2011.01.012
DOI	10.1016/J.CANLET.2011.01.012
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37846306
is cites work of	c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells. Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells Bifunctional Conjugates with Potent Inhibitory Activity Towards Cyclooxygenase and Histone Deacetylase The 'N-factors' in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers. Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions-in vitro study Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer Targeting cell death signaling in colorectal cancer: current strategies and future perspectives Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases Chronic inflammation in cancer development. Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice A multi-targeted approach to suppress tumor-promoting inflammation Apoptosis induction and tumor cell repopulation: the yin and yang of radiotherapy Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent Combination of celecoxib (Celebrex®) and CD19 CAR-redirected CTL immunotherapy for the treatment of B-cell non-Hodgkin's lymphomas Preventive effect of celecoxib use against cancer progression and occurrence of oral squamous cell carcinoma Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS) Celecoxib regulates apoptosis and autophagy via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer cells Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era. Clinical Profile of Cyclooxygenase-2 Inhibitors in Treating Non-Small Cell Lung Cancer: A Meta-Analysis of Nine Randomized Clinical Trials Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method COX inhibitors: a patent review (2011 - 2014). Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression. YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis Curcumol potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer. Goniothalamin and Celecoxib Effects During Aging: Targeting Pro-Inflammatory Mediators in Chemoprevention of Prostatic Disorders. Celecoxib in breast cancer prevention and therapy Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testing. Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles Clinical and prognostic association of oncogene cadherin 11 in gastric cancer Pathway analysis for drug repositioning based on public database mining Celecoxib and Bcl-2: emerging possibilities for anticancer drug design Triggering of suicidal erythrocyte death by celecoxib Lymphadenectomy promotes tumor growth and cancer cell dissemination in the spontaneous RET mouse model of human uveal melanoma Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice Apoptotic effects of two COX-2 inhibitors on breast adenocarcinoma cells through COX-2 independent pathway. Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapy The effect of celecoxib, a cyclooxygenase-2 inhibitor on noise- induced hearing loss Overcoming Resistance of Human Non-Hodgkin's Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors. The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software